Organon & Co | Rörelseresultat



Operating Profit Ändra Datum
Adcock Ingram Holdings ZAR 479.08M 106.67M 2024-06
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Celltrion KRW 207.69B 135.2B 2024-09
Cspc Pharmaceutical CNY 985M 796.94M 2024-09
Dianthus Therapeutics USD -31916000 2.02M 2024-12
Ecofibre AUD -4680000 38.98M 2024-06
Gilead Sciences USD 2.24B 215M 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Kangmei Pharma CNY -58945310 67.51M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 123.07M 85.91M 2024-12
Malin Corporation EUR -700000 1.6M 2024-06
Medical Developments International AUD -20243000 7.24M 2024-06
Merck USD 5.87B 1.57B 2025-03
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Novartis USD 3.4B 193M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Organon & Co USD 129M 78M 2024-12
Pharma Mar EUR -3085000 7.98M 2025-03
Qiagen NV USD 144.16M 14.73M 2024-12
Sartorius EUR 137.4M 2.6M 2025-03
Sino Biopharmaceutical CNY 1.33B 404.37M 2024-12
Tilray USD -42218000 5.65M 2024-11



Organon & Co Rörelseresultat - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.